AEGiS-Reuters: S. African businessman Tannenbaum denies $1.2 bln fraud

Reuters, Ltd.Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


S. African businessman Tannenbaum denies $1.2 bln fraud

Reuters NewMedia - June 12, 2009
Marius Bosch


* Says found himself in financial predicament

* Says time will show had defrauded no-one

JOHANNESBURG, June 12 (Reuters) - South African businessman Barry Tannenbaum, accused of defrauding hundreds of investors in what may be the country's biggest corporate fraud, denied any wrongdoing and blamed the economic crisis for his company's woes.

"As has happened with other companies that have from time to time found themselves in a financial predicament, particularly in the present climate, I have found myself in such a situation," he said in an e-mailed statement on Friday.

Tannenbaum, who lives in Australia, said he had defrauded no-one and described accusations against him as wild allegations, speculation and conjecture.

"In short, the hype at this stage is such that whatever I say, will be disbelieved. Time will demonstrate that I have defrauded no-one," Tannenbaum said.

Lawyers and investigators said on Thursday hundreds of investors, including top businessmen from South Africa, the United States, Germany and Australia, were affected.

Tannenbaum was said to have lured investors with the promise of 200 percent annual returns linked to pharmaceutical imports and was accused of forging AIDS drug orders to give reassurance when money started to dry up. [ID:nLBO25438]

The case could rank as South Africa's biggest corporate fraud and has shocked the country's business community, known for its conservative approach to risk and investment.

The South African Reserve Bank said it had become aware of the issue this week after complaints from investors who were no longer receiving their returns and would check if exchange control and banking rules had been broken.

Tannenbaum operated through his Frankel International and Frankel Chemical Corp companies and says in brochures his father was a founder of South Africa's No. 2 pharmaceuticals firm, Adcock Ingram (AIPJ.J: Quote, Profile, Research, Stock Buzz). Adcock said it was his grandfather.

Documents posted on the Internet by Investigator Specialised Services Group, a private law enforcement agency hired by investors to look into Tannenbaum, include what it said are forged purchase orders from Africa's biggest generic drugmaker, Aspen (APNJ.J: Quote, Profile, Research, Stock Buzz), which Tannenbaum allegedly used to show investors funds were coming soon.

Both Adcock and Aspen confirmed they had bought small amounts of supplies from Frankel, but said the purchase documents, including some involving life-prolonging anti-retroviral AIDS drugs, were fake. (Editing by David Holmes)


090612
RE090604


Copyright © 2009 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .